Proceedings of the First International Conference on Medical Technology (ICoMTech 2021)

Effectiveness of the Extract of Celery (Apium Graveolens L) Against Calculations Glucose In Vivo as Antidiabetic Alternatives

Authors
Idham Halid1, Ika Nurfajri Mentari1, *, Zuratun Navisa1, Bustanul Atfal1, Eva Luviriani2
1D3 Teknologi Laboratorium Medik, Politeknik Medica Farma Husada Mataram, Mataram, Indonesia
2S1 Farmasi STIKES An-Nasher Cirebon, Cirebon, Indonesia
*Corresponding author. Email: ikanurfajri26@gmail.com
Corresponding Author
Ika Nurfajri Mentari
Available Online 15 December 2022.
DOI
10.2991/978-94-6463-018-3_8How to use a DOI?
Keywords
Celery Leaves (Apium Graveolens L); Glucose; In vivo; Antidiabetic
Abstract

Diabetes Mellitus is a group of disorders characterized by increased blood glucose levels (hyperglycemia) and there may be a decrease in the ability to respond to insulin as well as a decrease in insulin formation by the pancreas. Celery plant is an herbal medicine with antidiabetic activity which is widely used because of its nature which is more suitable for the human body. The content found in celery leaves is flavonoids, terpenoids, alkaloids, and steroids. This study aims to determine whether celery leaf extract (Apium Graveolens L) can reduce blood glucose levels in male mice (Mus Musculus L) to determine the concentration of blood sugar levels which can reduce blood glucose levels in male mice (Mus Musculus L) and to analyzed the effect of celery leaf extract (Apium Graveolens L) on blood glucose levels in male mice (Mus Musculus L). The research method used was true experiment with pre test approach and post test only control group design. The results of the research on celery leaf extract (Apium Graveolens L) were proven to be able to reduce blood glucose levels in male mice (Mus Musculus L), which was the most effective in the P3 group with a dose of 177 mg/kgBW.

Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

Volume Title
Proceedings of the First International Conference on Medical Technology (ICoMTech 2021)
Series
Advances in Health Sciences Research
Publication Date
15 December 2022
ISBN
10.2991/978-94-6463-018-3_8
ISSN
2468-5739
DOI
10.2991/978-94-6463-018-3_8How to use a DOI?
Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

TY  - CONF
AU  - Idham Halid
AU  - Ika Nurfajri Mentari
AU  - Zuratun Navisa
AU  - Bustanul Atfal
AU  - Eva Luviriani
PY  - 2022
DA  - 2022/12/15
TI  - Effectiveness of the Extract of Celery (Apium Graveolens L) Against Calculations Glucose In Vivo as Antidiabetic Alternatives
BT  - Proceedings of the First International Conference on Medical Technology (ICoMTech 2021)
PB  - Atlantis Press
SP  - 55
EP  - 61
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-018-3_8
DO  - 10.2991/978-94-6463-018-3_8
ID  - Halid2022
ER  -